ACUTE MONOBLASTIC LEUKEMIA & TREATMENT
Definition: What is "Acute monoblastic leukemia"?
Acute monoblastic leukemia otherwise known as acute monocytic leukemia is an acute type of myeloid leukemia. For patients to be considered a victim of AML-M5, he must have more than 20% blasts in the marrow. Monoblasts are largely distinguished for displaying a rough, circular nucleus & a delicate lacy chromatin.
Symptoms & Signs
Among the usual indicators of acute monoblastic leukemia include asthenia or generalized weakness, pallor, unexplained fever, dizziness & other respiratory symptoms.
Treatment: How to Treat "Acute monoblastic leukemia"?
Like other forms of blood cancer, AML treatment would largely consist of chemotherapy, which is divided into two phases: the induction & postremission therapy. Induction is administered to induce complete & lasting remission by reducing the leukemic cells to untraceable levels. Consolidation aims to eliminate any existing or residual diseases.
There are a number of risk factor that were identified that largely contribute to the development of AML. Among these include pre-leukemic blood disorders, exposure to chemotherapy, ionizinf radiation, occupation chemical exposure & some congenital conditions such as Down syndrome.
The first clue of AML includes abnormal result of the patient's blood count. AML also presents isolated decrease in red blood cells, platelets & even an abnormally low white blood cell count. A bone marrow examination can also be performed to further identify the type of blood cells that have displayed abnormality.